查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球蛋白质表现市场（~2029）：产品类型（试剂、载体、胜任细胞、设备、软体）、服务、系统类型（哺乳动物（CHO/HEK293）、昆虫、酵母）、工作流程、应用（治疗、研究/产业）
市场调查报告书
商品编码
1594226

全球蛋白质表现市场（~2029）：产品类型（试剂、载体、胜任细胞、设备、软体）、服务、系统类型（哺乳动物（CHO/HEK293）、昆虫、酵母）、工作流程、应用（治疗、研究/产业）

Protein Expression Market by Product (Reagents, Vectors, Competent Cells, Instruments, Software), Services, System Type (Mammalian (CHO, HEK293), Insect, Yeast), Workflow, Application (Therapeutic, Research, Industrial) - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 471 Pages | 订单完成后即时交付

价格

全球蛋白质表现市场规模预计将从 2024 年的 34.1 亿美元成长到 2029 年的 48.2 亿美元，预测期内复合年增长率为 7.1%。

製药和生物製药行业研发活动的增加对生技药品的需求增加以及人工智慧和机器学习的使用增加以加强基于蛋白质的研究等因素正在支撑市场成长。此外，向个人化药物开发的转变、临床活动外包服务的增加、对基于植物和无细胞表达系统的使用的日益重视以及合成蛋白质生产技术的发展等因素正在推动蛋白质表达的增长市场为公司提供了成长机会。

调查范围
调查年份 2022-2029
基准年 2023年
预测期 2024-2029/td>
单元 金额（美元）
按细分市场 按系统类型、供应类别、工作流程、应用程式、产品最终用户、服务最终用户、区域
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

“按产品领域来看，该产品领域预计将在预测期内呈现最高增长率。”

产品部门在 2023 年录得最高成长率。基于蛋白质的研究的增加以及抗体和疫苗等生技药品的核准和商业化的增加等因素正在支持该行业的高速成长。产品部门包括试剂和套件、表现载体、胜任细胞、支持蛋白质表现各阶段的设备。由于蛋白质表现工作流程的持续需求，在产品中，试剂和套件的销售量最大。蛋白质表现技术的进步以及新型高效试剂和套件的推出也支持了该部门的发展。此外，对抗体和疫苗等个人化医疗和生技药品的日益关注也增加了对这些产品的需求。

“从最终用户来看，学术研究机构预计将在预测期内呈现最高增长率。”

政府和製药公司不断增加的资金和津贴增加了对生物和生物医学研究创新研究解决方案的需求，支持了该行业的快速成长。研究机构和製药公司之间的合作也在增加，以开发基于蛋白质的治疗方法，例如用于治疗各种慢性疾病的抗体和疫苗。预计这种高成长将在预测期内持续下去。

《北美：最大且成长最快的地区》

预计北美蛋白质表现市场在预测期内将达到最高成长率。专注于开发基于蛋白质的治疗方法的成熟生物技术和製药行业的存在导致了对蛋白质表现产品和服务的高需求。该地区拥有主要的蛋白质表现产品和服务供应商、最终用户、先进的研究设施以及大量的研发资金。癌症和糖尿病等慢性疾病的增加也推动了对新型蛋白质药物的需求，并增加了对高效蛋白质表现技术的需求。此外，政府对生命科学研究的支持和资助也支持了北美在全球蛋白质表现市场的庞大市场占有率。

本报告调查了全球蛋白质表现市场，并提供了市场概况、市场成长的各种影响因素分析、技术和专利趋势、法律制度、案例研究、市场规模趋势和预测、各种分类，它总结了详细分析地区/主要国家、竞争环境、主要企业概况等

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
  • 影响客户业务的趋势/干扰
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 生态系分析
  • 投资/资金筹措活动
  • 技术分析
  • 专利分析
  • 贸易分析
  • 重大会议及活动
  • 监管分析
  • 波特五力分析
  • 主要相关利益者和采购标准
  • 人工智慧/产生人工智慧对蛋白质表现市场的影响

第六章蛋白质表现市场：依报价细分

  • 产品
    • 试剂/套件
    • 表达载体
    • 胜任细胞
    • 设备/软体
  • 服务

第七章蛋白质表现市场：依系统类型

  • 哺乳动物细胞表现系统
    • 中国仓鼠卵巢（CHO）细胞系统
    • 人类胚胎肾 (HEK 293) 细胞系统
    • 其他的
  • 原核表达系统
    • 大肠桿菌系统
    • 其他的
  • 昆虫细胞表现系统
    • 桿状病毒系统
    • 其他的
  • 酵母表现系统
    • 毕赤酵母系统
    • 酵母系统
    • 其他的
  • 无细胞表现系统
  • 基于藻类的表达系统

第 8 章蛋白质表现市场：依工作流程

  • 克隆/转染
  • 转录、翻译、转译后修饰（PTM）
  • 萃取、精製和表征

第九章蛋白质表现市场：依应用分类

  • 治疗
  • 研究
  • 产业

第 10 章 蛋白质表现产品市场：依最终用户分类

  • 製药和生物技术公司
  • 学术研究所
  • 交叉·CDMOS
  • 其他的

第十一章蛋白质表现服务市场：依最终用户分类

  • 製药和生物技术公司
  • 学术研究所
  • 其他的

第十二章蛋白质表现市场：按地区

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第十三章竞争格局

  • 概述
  • 主要企业/主要企业策略
  • 收益分析
  • 市场占有率分析
  • 企业评价矩阵：主要企业
  • 公司评估矩阵：Start-Ups企业/中小企业
  • 企业价值评估及财务指标
  • 品牌/产品比较
  • 竞争场景

第十四章 公司简介

  • 主要企业
    • THERMO FISHER SCIENTIFIC INC.
    • MERCK KGAA
    • DANAHER CORPORATION
    • AGILENT TECHNOLOGIES, INC.
    • SARTORIUS AG
    • GENSCRIPT
    • TAKARA BIO INC.
    • BIO-RAD LABORATORIES, INC.
    • QIAGEN
    • CHARLES RIVER LABORATORIES
    • CORNING INCORPORATED
    • LONZA
    • FUJIFILM IRVINE SCIENTIFIC, INC.
    • SYNGENE INTERNATIONAL LIMITED
    • LGC LIMITED
    • EUROFINS SCIENTIFIC
    • AJINOMOTO CO., INC.
  • 其他公司
    • PROMEGA CORPORATION
    • SINO BIOLOGICAL, INC.
    • RAYBIOTECH, INC.
    • BIONEER CORPORATION
    • ORIGENE TECHNOLOGIES, INC.
    • NEW ENGLAND BIOLABS
    • ACCURUS BIOSCIENCES
    • ARAGEN LIFE SCIENCES LTD.
    • OXFORD EXPRESSION TECHNOLOGIES LTD
    • PROTEOGENIX INC.
    • ABEOMICS

第十五章附录

Product Code: BT 2435

The global Protein Expression market is projected to reach USD 4.82 billion in 2029 and is from USD 3.41 billion by 2024, at a CAGR of 7.1% during the forecast period. Factors such as the increasing demand for biologics supported by the rise in R&D activities in the pharmaceutical and biopharmaceutical industry and the growing use of artificial intelligence and machine learning to enhance protein-based studies are supporting the growth of the market. Moreover, factors such as the ongoing shift toward the development of personalized medicines, the rise in outsourcing services for clinical activities, the growing emphasis on the use of plant-based and cell-free expression systems, and the development of synthetic protein production technologies provide growth opportunities for players within the protein expression market. However, the high cost of protein expression reagents and instruments and the challenges associated with various expression systems are expected to restrain the growth of this market.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsBy System Type, Offerings, Workflow, Application, Product End user, Service End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

"The product segment registered the highest growth rate in the protein expression market, by offerings, during the forecast period"

In 2023, the products segment registered the highest growth rate within the protein expression market by offerings. Factors such as the rise in protein-based research and increasing approvals and commercialization of biologics, such as antibodies and vaccines are supporting the high growth of this segment. The products segment includes various reagents & kits, expression vectors, competent cells, and instruments that aid during various phases of protein expression. Reagents & kits accounted for the largest segment of the protein expression products market due to the continuous demand for these products during the protein expression workflow. Advancements in protein expression technologies and the launch of new and efficient reagents and kits are also supporting the growth of this product segment. Additionally, the rising focus on personalized medicine and biologics, such as antibodies and vaccines, is creating more demand for these products.

"The academic research institutes registered the highest growth rate in the protein expression services market, by end user, during the forecast period"

The academic research institute end user segment registered the highest growth rate within the protein expression services market by end user during the forecast period. Factors such as the increasing demand for innovative research solutions for biological and biomedical research supported by an increase in funding and grants from governments and pharmaceutical companies are supporting the high growth of this end user segment. Moreover, there is an increase in the number of collaborations between research institutes and pharmaceutical companies for the development of protein-based therapies such as antibodies and vaccines for the treatment of various chronic illnesses. This high growth is projected to continue during the forecast period.

"North America: The largest and fastest-growing region in the Protein Expression market"

The protein expression market in North America is projected to register the highest growth rate during the forecast period. This high growth is attributed to the presence of an established biotechnology and pharmaceuticals sector focusing on the development of protein-based therapies leading to a high demand for protein expression products and services. The region has key protein expression products and services suppliers and end-users as well as advanced research facilities and large R&D expenditures. In addition, the rise of chronic conditions such as cancer and diabetes has also supported the need for new protein-based drugs, increasing the demand for efficient protein expression technologies. In addition, the support and funding from the government for life sciences research also support the large market share of North America in the global protein expression market.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 32%, Tier 2 - 44%, and Tier 3 - 24%
  • By Designation: (Managers) - 45%, (CXOs, Directors)- 30%, and(Executives) - 25%
  • By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -5%, Middle East- 5%, Africa-5%

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc. (US)
  • Merck KGaA (Germany)
  • GenScript (US)
  • Agilent Technologies, Inc. (US)
  • Takara Bio Inc. (Japan)
  • Lonza (Switzerland)
  • Promega Corporation (US)
  • OriGene Technologies, Inc. (US)
  • Qiagen (Netherlands)
  • Bio-Rad Laboratories, Inc. (US)
  • Danaher Corporation (US)
  • Sartorius AG (Germany)
  • FUJIFILM Irvine Scientific, Inc. (Japan)
  • Bioneer Corporation (South Korea)
  • LGC Limited (UK)
  • Sino Biological, Inc. (China)
  • New England BioLabs (US)
  • LifeSensors Inc. (US)
  • Jena Bioscience GmbH (Germany)
  • Charles River Laboratories (US)
  • Corning Incorporated (US)
  • Eurofins Scientific (Luxembourg)
  • Ajinomoto Co., Inc. (Ajinomoto Bio-Pharma Services) (Japan)
  • Syngene International Limited (India)
  • Aragen Life Sciences Ltd. (India)

Research Coverage:

This report provides a detailed picture of the global Protein Expression Market. It aims at estimating the size and future growth potential of the market across different segments such as the system type, offerings, workflow, application, products end user, services end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the protein expression market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements, new product & service launches, mergers and acquisitions, and recent developments associated with the protein expression market. Competitive analysis of upcoming startups in the protein expression market ecosystem is covered in this report.

Reasons to buy this report :

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall protein expression market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing demand for biologics, Rise in R&D in pharmaceutical and biopharmaceutical industries, Growing use of artificial intelligence and machine learning, Increasing shift toward personalized medicines, and Growing outsourcing of clinical activities), restraints (High cost of protein expression offerings and the dominance of small molecules in drug development), opportunities (Growing emphasis on plant-based and cell-free expression systems, Booming markets in emerging economies, Increasing development of new synthetic protein production technologies, and Growing use of recombinant proteins), and challenges (Production cost and efficiency issues) influencing the growth of the protein expression market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the protein expression market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the protein expression market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the protein expression market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Agilent Technologies, Inc. (US), Sartorius AG (Germany), GenScript (US), Takara Bio Inc. (Japan), Lonza (Switzerland), among others in protein expression market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 MARKET ESTIMATION
    • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
    • 2.2.3 TOP-DOWN APPROACH
  • 2.3 MARKET GROWTH RATE PROJECTIONS
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 PROTEIN EXPRESSION MARKET OVERVIEW
  • 4.2 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING AND COUNTRY, 2023
  • 4.3 PROTEIN EXPRESSION MARKET SHARE, BY SYSTEM TYPE, 2024 VS. 2029
  • 4.4 PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2023
  • 4.5 PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2023
  • 4.6 PROTEIN EXPRESSION MARKET, BY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for biologics
      • 5.2.1.2 Rise in R&D in pharmaceutical and biopharmaceutical industries
      • 5.2.1.3 Growing use of artificial intelligence and machine learning
      • 5.2.1.4 Increasing shift toward personalized medicines
      • 5.2.1.5 Growing outsourcing of clinical activities
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of protein expression offerings
      • 5.2.2.2 Renewed focus on small molecules in drug development
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing emphasis on plant-based and cell-free expression systems
      • 5.2.3.2 Booming market in emerging economies
      • 5.2.3.3 Increasing development of synthetic protein production technologies
      • 5.2.3.4 Growing use of recombinant proteins
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Production cost and efficiency issues
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 PRICING ANALYSIS
    • 5.4.1 AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION PRODUCTS
    • 5.4.2 AVERAGE SELLING PRICE, BY KEY PLAYER
      • 5.4.2.1 Average selling price of system types, by key player
      • 5.4.2.2 Average selling price trend of protein expression instruments, by key player
    • 5.4.3 AVERAGE SELLING PRICE, BY REGION
      • 5.4.3.1 Average selling price of protein expression consumable products, by region
      • 5.4.3.2 Average selling price trend of protein expression instruments, by region
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 INVESTMENT/FUNDING ACTIVITY
  • 5.9 TECHNOLOGY ANALYSIS
    • 5.9.1 KEY TECHNOLOGIES
      • 5.9.1.1 Recombinant DNA technology
      • 5.9.1.2 Transfection technologies
        • 5.9.1.2.1 Reagent-based transfection
        • 5.9.1.2.2 Instrument-based transfection
        • 5.9.1.2.3 Virus-based transfection
      • 5.9.1.3 Protein expression systems
        • 5.9.1.3.1 Bacterial expression systems
        • 5.9.1.3.2 Mammalian expression systems
        • 5.9.1.3.3 Yeast expression systems
        • 5.9.1.3.4 Insect expression systems
        • 5.9.1.3.5 Cell-free expression systems
    • 5.9.2 ADJACENT TECHNOLOGIES
      • 5.9.2.1 Extraction technologies
        • 5.9.2.1.1 Non-mechanical methods
        • 5.9.2.1.2 Mechanical methods
      • 5.9.2.2 Purification and characterization technologies
        • 5.9.2.2.1 Protein purification technologies
        • 5.9.2.2.2 Protein characterization technologies
    • 5.9.3 COMPLEMENTARY TECHNOLOGIES
      • 5.9.3.1 High-throughput technologies
      • 5.9.3.2 Computation protein designing
  • 5.10 PATENT ANALYSIS
  • 5.11 TRADE ANALYSIS
    • 5.11.1 IMPORT DATA
    • 5.11.2 EXPORT DATA
  • 5.12 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.13 REGULATORY ANALYSIS
    • 5.13.1 REGULATORY LANDSCAPE
      • 5.13.1.1 North America
      • 5.13.1.2 Europe
      • 5.13.1.3 Emerging economies
    • 5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.14 PORTER'S FIVE FORCES ANALYSIS
    • 5.14.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.14.2 BARGAINING POWER OF SUPPLIERS
    • 5.14.3 BARGAINING POWER OF BUYERS
    • 5.14.4 THREAT OF NEW ENTRANTS
    • 5.14.5 THREAT OF SUBSTITUTES
  • 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.15.2 BUYING CRITERIA
      • 5.15.2.1 Buying criteria for protein expression products
      • 5.15.2.2 Buying criteria for protein expression services
  • 5.16 IMPACT OF AI/GEN AI ON PROTEIN EXPRESSION MARKET
    • 5.16.1 INTRODUCTION
    • 5.16.2 MARKET POTENTIAL FOR PROTEIN EXPRESSION APPLICATIONS
    • 5.16.3 AI USE CASES
    • 5.16.4 KEY COMPANIES IMPLEMENTING AI
    • 5.16.5 FUTURE OF GENERATIVE AI IN PROTEIN EXPRESSION ECOSYSTEM

6 PROTEIN EXPRESSION MARKET, BY OFFERING

  • 6.1 INTRODUCTION
  • 6.2 PRODUCTS
    • 6.2.1 REAGENTS & KITS
      • 6.2.1.1 Increasing use for cloning, transfection, purification, and characterization to spur growth
    • 6.2.2 EXPRESSION VECTORS
      • 6.2.2.1 Growing production of complex proteins to propel market
    • 6.2.3 COMPETENT CELLS
      • 6.2.3.1 Increasing demand for therapeutic proteins to expedite growth
    • 6.2.4 INSTRUMENTS & SOFTWARE
      • 6.2.4.1 Increasing demand for biopharmaceuticals and personalized therapies to augment growth
  • 6.3 SERVICES
    • 6.3.1 GROWING UTILIZATION OF PROTEIN EXPRESSION SERVICES FOR LARGE-SCALE PRODUCTION TO FUEL MARKET

7 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE

  • 7.1 INTRODUCTION
  • 7.2 MAMMALIAN CELL EXPRESSION SYSTEMS
    • 7.2.1 CHINESE HAMSTER OVARY (CHO) CELL SYSTEMS
      • 7.2.1.1 High viability, rapid growth, and improved expression levels to support growth
    • 7.2.2 HUMAN EMBRYONIC KIDNEY (HEK 293) CELL SYSTEMS
      • 7.2.2.1 Wide usage in transient transfection studies to augment growth
    • 7.2.3 OTHER MAMMALIAN CELL SYSTEMS
  • 7.3 PROKARYOTIC EXPRESSION SYSTEMS
    • 7.3.1 ESCHERICHIA COLI SYSTEMS
      • 7.3.1.1 High cell density and low cost of media to stimulate growth
    • 7.3.2 OTHER PROKARYOTIC EXPRESSION SYSTEMS
  • 7.4 INSECT CELL EXPRESSION SYSTEMS
    • 7.4.1 BACULOVIRUS SYSTEMS
      • 7.4.1.1 Increasing production of biologically active and functional recombinant proteins to speed up growth
    • 7.4.2 OTHER INSECT CELL EXPRESSION SYSTEMS
  • 7.5 YEAST EXPRESSION SYSTEMS
    • 7.5.1 PICHIA SYSTEMS
      • 7.5.1.1 Rising production of antibody fragments, and vaccines to fuel growth
    • 7.5.2 SACCHAROMYCES SYSTEMS
      • 7.5.2.1 Increasing use of saccharomyces systems for producing heterologous proteins to accelerate growth
    • 7.5.3 OTHER YEAST EXPRESSION SYSTEMS
  • 7.6 CELL-FREE EXPRESSION SYSTEMS
    • 7.6.1 INCREASING DEMAND FOR RECOMBINANT PROTEINS TO SUPPORT MARKET
  • 7.7 ALGAL-BASED EXPRESSION SYSTEMS
    • 7.7.1 GROWING USE OF ALGAL-BASED EXPRESSION SYSTEMS IN ANTIBODY AND VACCINE GENERATION TO BOOST MARKET

8 PROTEIN EXPRESSION MARKET, BY WORKFLOW

  • 8.1 INTRODUCTION
  • 8.2 CLONING & TRANSFECTION
    • 8.2.1 CONTINUOUS REPLENISHMENT OF CONSUMABLES AND REAGENTS TO SUPPORT MARKET
  • 8.3 TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION (PTM)
    • 8.3.1 GROWING NEED FOR FUNCTIONAL AND STABLE PROTEINS TO DRIVE MARKET
  • 8.4 EXTRACTION, PURIFICATION, AND CHARACTERIZATION
    • 8.4.1 NEED TO ADHERE TO REQUIRED STANDARDS FOR SUITABLE APPLICATIONS TO DRIVE MARKET

9 PROTEIN EXPRESSION MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 THERAPEUTIC APPLICATIONS
    • 9.2.1 RISING DEMAND FOR BIOLOGICS THERAPIES TO FACILITATE GROWTH
  • 9.3 RESEARCH APPLICATIONS
    • 9.3.1 GROWING INTEREST IN PROTEOMICS, GENOMICS, AND DRUG DISCOVERY TO BOOST MARKET
  • 9.4 INDUSTRIAL APPLICATIONS
    • 9.4.1 INCREASING USE OF PROTEINS IN COSMETICS, TEXTILES, AND INDUSTRIAL ENZYMES TO PROMOTE GROWTH

10 PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.2.1 INCREASING APPROVALS FOR BIOLOGICS TO STIMULATE GROWTH
  • 10.3 ACADEMIC & RESEARCH INSTITUTES
    • 10.3.1 RISE IN GOVERNMENT AND PRIVATE FUNDING TO CONTRIBUTE TO MARKET GROWTH
  • 10.4 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CROS & CDMOS)
    • 10.4.1 INCREASING OUTSOURCING AND COLLABORATIONS FOR PHARMACEUTICAL MANUFACTURING AND CLINICAL TRIALS TO SUSTAIN MARKET
  • 10.5 OTHER END USERS

11 PROTEIN EXPRESSION SERVICES MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 11.2.1 INCREASING SHIFT TOWARD DRUG DEVELOPMENT OUTSOURCING TO FAVOR GROWTH
  • 11.3 ACADEMIC & RESEARCH INSTITUTES
    • 11.3.1 RISING PARTNERSHIPS BETWEEN ACADEMIA AND CONTRACT RESEARCH ORGANIZATIONS TO AID GROWTH
  • 11.4 OTHER END USERS

12 PROTEIN EXPRESSION MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 12.2.2 US
      • 12.2.2.1 Growing focus on developing new therapeutics and protein-based drugs to drive market
    • 12.2.3 CANADA
      • 12.2.3.1 Increasing incidence of cancer and prevalence of public-private partnerships to sustain growth
  • 12.3 EUROPE
    • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 12.3.2 GERMANY
      • 12.3.2.1 Increasing proteomics-based research and healthcare investments to promote growth
    • 12.3.3 UK
      • 12.3.3.1 Growing development of immunotherapies, vaccines, and proteomics to fuel market
    • 12.3.4 FRANCE
      • 12.3.4.1 Rise in funding for proteomics and genomics to spur growth
    • 12.3.5 ITALY
      • 12.3.5.1 Growing life science research supported by universities and research institutions to boost market
    • 12.3.6 SPAIN
      • 12.3.6.1 Increasing international collaborations for drug development to fuel market
    • 12.3.7 NETHERLANDS
      • 12.3.7.1 Presence of advanced infrastructure to fuel market
    • 12.3.8 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 12.4.2 CHINA
      • 12.4.2.1 Extensive government funding in genomics and protein research to boost market
    • 12.4.3 JAPAN
      • 12.4.3.1 Increasing initiatives by government associations in life sciences sector to support market growth
    • 12.4.4 INDIA
      • 12.4.4.1 Rising collaborations between private sector and academia to facilitate growth
    • 12.4.5 AUSTRALIA
      • 12.4.5.1 Growing focus on developing new proteins and peptides to drive market
    • 12.4.6 SOUTH KOREA
      • 12.4.6.1 Increasing research & development of novel therapies to facilitate growth
    • 12.4.7 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 12.5.2 BRAZIL
      • 12.5.2.1 Growing industrial investments to propel market
    • 12.5.3 MEXICO
      • 12.5.3.1 Increase in chronic diseases and robust research ecosystem to expedite growth
    • 12.5.4 ARGENTINA
      • 12.5.4.1 Rise in biotechnology and pharmaceutical research & development to augment growth
    • 12.5.5 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST
    • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
    • 12.6.2 GCC COUNTRIES
      • 12.6.2.1 Strategic investments between government authorities and private players to drive market
    • 12.6.3 REST OF MIDDLE EAST
  • 12.7 AFRICA
    • 12.7.1 FAVORABLE INSURANCE PROGRAMS AND CLINICAL TRIALS TO CONTRIBUTE TO MARKET GROWTH
    • 12.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN, 2021-2024
  • 13.3 REVENUE ANALYSIS, 2021-2023
  • 13.4 MARKET SHARE ANALYSIS, 2023
  • 13.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2023
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
    • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 13.5.5.1 Company footprint
      • 13.5.5.2 Region footprint
      • 13.5.5.3 Offering footprint
      • 13.5.5.4 Expression system footprint
      • 13.5.5.5 Application footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 RESPONSIVE COMPANIES
    • 13.6.3 DYNAMIC COMPANIES
    • 13.6.4 STARTING BLOCKS
    • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 13.6.5.1 Detailed list of key startups/SMES
      • 13.6.5.2 Competitive benchmarking of startups/SMEs
  • 13.7 COMPANY VALUATION AND FINANCIAL METRICS
    • 13.7.1 COMPANY VALUATION
    • 13.7.2 FINANCIAL METRICS
  • 13.8 BRAND/PRODUCT COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 PRODUCT/SERVICE LAUNCHES
    • 13.9.2 DEALS
    • 13.9.3 EXPANSIONS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 THERMO FISHER SCIENTIFIC INC.
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products and services offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Product/Service launches
        • 14.1.1.3.2 Deals
        • 14.1.1.3.3 Expansions
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Key strengths
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses and competitive threats
    • 14.1.2 MERCK KGAA
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products and services offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Deals
        • 14.1.2.3.2 Expansions
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Key strengths
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses and competitive threats
    • 14.1.3 DANAHER CORPORATION
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products and services offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Product/Service launches
        • 14.1.3.3.2 Deals
        • 14.1.3.3.3 Expansions
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Key strengths
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses and competitive threats
    • 14.1.4 AGILENT TECHNOLOGIES, INC.
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products and services offered
      • 14.1.4.3 MnM view
        • 14.1.4.3.1 Key strengths
        • 14.1.4.3.2 Strategic choices
        • 14.1.4.3.3 Weaknesses and competitive threats
    • 14.1.5 SARTORIUS AG
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products and services offered
      • 14.1.5.3 Recent developments
        • 14.1.5.3.1 Deals
        • 14.1.5.3.2 Expansions
      • 14.1.5.4 MnM view
        • 14.1.5.4.1 Key strength
        • 14.1.5.4.2 Strategic choices
        • 14.1.5.4.3 Weaknesses and competitive threats
    • 14.1.6 GENSCRIPT
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products and services offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Product/Service launches
      • 14.1.6.4 MnM view
        • 14.1.6.4.1 Key strengths
        • 14.1.6.4.2 Strategic choices
        • 14.1.6.4.3 Weaknesses and competitive threats
    • 14.1.7 TAKARA BIO INC.
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products and services offered
    • 14.1.8 BIO-RAD LABORATORIES, INC.
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products and services offered
    • 14.1.9 QIAGEN
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products and services offered
    • 14.1.10 CHARLES RIVER LABORATORIES
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products and services offered
    • 14.1.11 CORNING INCORPORATED
      • 14.1.11.1 Business overview
      • 14.1.11.2 Products and services offered
    • 14.1.12 LONZA
      • 14.1.12.1 Business overview
      • 14.1.12.2 Products and services offered
      • 14.1.12.3 Recent developments
        • 14.1.12.3.1 Product/Service launches
        • 14.1.12.3.2 Deals
    • 14.1.13 FUJIFILM IRVINE SCIENTIFIC, INC.
      • 14.1.13.1 Business overview
      • 14.1.13.2 Products and services offered
      • 14.1.13.3 Recent developments
        • 14.1.13.3.1 Product/Service launches
        • 14.1.13.3.2 Deals
        • 14.1.13.3.3 Expansions
    • 14.1.14 SYNGENE INTERNATIONAL LIMITED
      • 14.1.14.1 Business overview
      • 14.1.14.2 Products and services offered
      • 14.1.14.3 Recent developments
        • 14.1.14.3.1 Product/Service launches
    • 14.1.15 LGC LIMITED
      • 14.1.15.1 Business overview
      • 14.1.15.2 Products and services offered
    • 14.1.16 EUROFINS SCIENTIFIC
      • 14.1.16.1 Business overview
      • 14.1.16.2 Products and services offered
    • 14.1.17 AJINOMOTO CO., INC.
      • 14.1.17.1 Business overview
      • 14.1.17.2 Products and services offered
  • 14.2 OTHER PLAYERS
    • 14.2.1 PROMEGA CORPORATION
    • 14.2.2 SINO BIOLOGICAL, INC.
    • 14.2.3 RAYBIOTECH, INC.
    • 14.2.4 BIONEER CORPORATION
    • 14.2.5 ORIGENE TECHNOLOGIES, INC.
    • 14.2.6 NEW ENGLAND BIOLABS
    • 14.2.7 ACCURUS BIOSCIENCES
    • 14.2.8 ARAGEN LIFE SCIENCES LTD.
    • 14.2.9 OXFORD EXPRESSION TECHNOLOGIES LTD
    • 14.2.10 PROTEOGENIX INC.
    • 14.2.11 ABEOMICS

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 PROTEIN EXPRESSION MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 3 PROTEIN EXPRESSION MARKET: RISK ASSESSMENT
  • TABLE 4 PROTEIN EXPRESSION MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 5 BIOLOGICS AND CELL LINES FOR PRODUCTION
  • TABLE 6 PROTEINS SYNTHESIZED BY PROTEIN EXPRESSION AND GENETIC ENGINEERING
  • TABLE 7 AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION PRODUCTS, 2021-2023 (USD)
  • TABLE 8 AVERAGE SELLING PRICE OF SYSTEM TYPES, BY KEY PLAYER, 2023 (USD)
  • TABLE 9 AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION INSTRUMENTS, BY KEY PLAYER, 2021-2023 (USD)
  • TABLE 10 AVERAGE SELLING PRICE OF PROTEIN EXPRESSION CONSUMABLE PRODUCTS, BY REGION, 2023 (USD)
  • TABLE 11 AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION INSTRUMENTS, BY REGION, 2021-2023 (USD)
  • TABLE 12 PROTEIN EXPRESSION MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 13 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
  • TABLE 14 PROTEIN EXPRESSION MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2022-2024
  • TABLE 15 IMPORT DATA FOR MASS SPECTROMETERS HS CODE (902781), 2022-2023, (USD THOUSAND)
  • TABLE 16 IMPORT DATA FOR MASS SPECTROMETERS HS CODE (902781), 2022-2023, (UNIT)
  • TABLE 17 EXPORT DATA FOR MASS SPECTROMETERS HS CODE (902781), 2022-2023, (USD THOUSAND)
  • TABLE 18 EXPORT DATA FOR MASS SPECTROMETERS HS CODE (902781), 2022-2023, (UNIT)
  • TABLE 19 PROTEIN EXPRESSION MARKET: KEY CONFERENCES AND EVENTS, 2024-2025
  • TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 25 PROTEIN EXPRESSION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
  • TABLE 27 BUYING CRITERIA FOR PROTEIN EXPRESSION PRODUCTS, BY END USER
  • TABLE 28 BUYING CRITERIA FOR PROTEIN EXPRESSION SERVICES, BY END USER
  • TABLE 29 PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 30 PROTEIN EXPRESSION PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 31 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 36 PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 37 PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 38 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 43 PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 44 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 49 PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 54 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 55 PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 56 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS AND SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 61 PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 67 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 68 PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 70 EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 72 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 74 PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 75 PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 77 EUROPE: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 79 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 80 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 81 PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 82 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 83 EUROPE: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 85 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 86 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 87 PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 89 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 91 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 92 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 93 PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 97 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 98 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 99 PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 100 PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 101 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 102 EUROPE: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 104 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 105 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 106 PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 107 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 108 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 110 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 111 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 112 PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 113 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 114 EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 116 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 117 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 118 PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 119 PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 120 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 121 EUROPE: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 123 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 124 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 125 PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 126 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 127 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 129 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 130 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 131 PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 132 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 133 EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 135 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 136 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 137 PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 138 PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 139 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 140 EUROPE: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 142 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 143 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 144 PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 145 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 146 EUROPE: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 148 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 149 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 150 PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 151 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 152 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 154 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 155 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 156 PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 157 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 158 EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 160 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 161 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 162 PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 163 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 164 EUROPE: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 166 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 167 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 168 PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 169 PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 170 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 171 EUROPE: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 173 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 174 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 175 PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 176 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 177 EUROPE: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 178 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 179 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 180 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 181 PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 182 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 183 EUROPE: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 184 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 185 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 186 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 187 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 188 PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 189 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 190 EUROPE: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 191 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 192 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 193 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 194 PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 195 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 196 EUROPE: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 197 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 198 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 199 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 200 LIST OF INDUSTRIAL ENZYMES AND APPLICATIONS
  • TABLE 201 PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 202 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 203 EUROPE: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 204 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 205 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 206 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 207 PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 208 PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 209 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 210 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 211 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 212 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 213 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 214 PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 215 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 216 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 218 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 219 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 220 PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 221 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 222 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 223 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 224 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 225 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 226 PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 227 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 228 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 229 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 230 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 231 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 232 PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 233 PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 234 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 235 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 236 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 237 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 238 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 239 PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 240 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 241 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 242 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 243 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 244 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 245 PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 246 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 247 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 248 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 249 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 250 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 251 PROTEIN EXPRESSION MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 252 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 253 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 254 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 255 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 256 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 257 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 258 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 259 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 260 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 261 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 262 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 263 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 264 NORTH AMERICA: KEY MACROECONOMIC INDICATORS
  • TABLE 265 US: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 266 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 267 US: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 268 US: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 269 US: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 270 US: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 271 US: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 272 US: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 273 US: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 274 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 275 US: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 276 CANADA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 277 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 278 CANADA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 279 CANADA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 280 CANADA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 281 CANADA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 282 CANADA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 283 CANADA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 284 CANADA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 285 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 286 CANADA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 287 EUROPE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 288 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 289 EUROPE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 290 EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 291 EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 292 EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 293 EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 294 EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 295 EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 296 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 297 EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 298 EUROPE: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 299 EUROPE: KEY MACROECONOMIC INDICATORS
  • TABLE 300 GERMANY: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 301 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 302 GERMANY: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 303 GERMANY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 304 GERMANY: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 305 GERMANY: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 306 GERMANY: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 307 GERMANY: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 308 GERMANY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 309 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 310 GERMANY: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 311 UK: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 312 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 313 UK: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 314 UK: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 315 UK: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 316 UK: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 317 UK: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 318 UK: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 319 UK: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 320 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 321 UK: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 322 FRANCE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 323 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 324 FRANCE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 325 FRANCE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 326 FRANCE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 327 FRANCE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 328 FRANCE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 329 FRANCE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 330 FRANCE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 331 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 332 FRANCE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 333 ITALY: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 334 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 335 ITALY: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 336 ITALY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 337 ITALY: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 338 ITALY: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 339 ITALY: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 340 ITALY: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 341 ITALY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 342 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 343 ITALY: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 344 SPAIN: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 345 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 346 SPAIN: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 347 SPAIN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 348 SPAIN: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 349 SPAIN: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 350 SPAIN: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 351 SPAIN: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 352 SPAIN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 353 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 354 SPAIN: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 355 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 356 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 357 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 358 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 359 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 360 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 361 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 362 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 363 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 364 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 365 NETHERLANDS: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 366 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 367 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 368 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 369 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 370 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 371 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 372 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 373 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 374 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 375 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 376 REST OF EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 377 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 378 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 379 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 380 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 381 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 382 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 383 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 384 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 385 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 386 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 387 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 388 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 389 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
  • TABLE 390 CHINA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 391 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 392 CHINA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 393 CHINA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 394 CHINA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 395 CHINA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 396 CHINA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 397 CHINA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 398 CHINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 399 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 400 CHINA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 401 JAPAN: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 402 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 403 JAPAN: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 404 JAPAN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 405 JAPAN: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 406 JAPAN: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 407 JAPAN: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 408 JAPAN: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 409 JAPAN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 410 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 411 JAPAN: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 412 INDIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 413 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 414 INDIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 415 INDIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 416 INDIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 417 INDIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 418 INDIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 419 INDIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 420 INDIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 421 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 422 INDIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 423 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 424 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 425 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 426 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 427 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 428 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 429 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 430 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 431 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 432 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 433 AUSTRALIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 434 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 435 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 436 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 437 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 438 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 439 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 440 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 441 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 442 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 443 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 444 SOUTH KOREA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 445 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 446 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 447 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 448 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 449 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 450 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 451 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 452 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 453 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 454 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 455 REST OF ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 456 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 457 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 458 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 459 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 460 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 461 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 462 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 463 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 464 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 465 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 466 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 467 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 468 LATIN AMERICA: KEY MACROECONOMIC INDICATORS
  • TABLE 469 BRAZIL: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 470 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 471 BRAZIL: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 472 BRAZIL: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 473 BRAZIL: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 474 BRAZIL: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 475 BRAZIL: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 476 BRAZIL: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 477 BRAZIL: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 478 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 479 BRAZIL: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 480 MEXICO: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 481 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 482 MEXICO: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 483 MEXICO: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 484 MEXICO: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 485 MEXICO: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 486 MEXICO: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 487 MEXICO: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 488 MEXICO: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 489 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 490 MEXICO: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 491 ARGENTINA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 492 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 493 ARGENTINA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 494 ARGENTINA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 495 ARGENTINA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 496 ARGENTINA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 497 ARGENTINA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 498 ARGENTINA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 499 ARGENTINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 500 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 501 ARGENTINA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 502 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 503 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 504 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 505 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 506 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 507 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 508 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 509 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 510 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 511 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 512 REST OF LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 513 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 514 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 515 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 516 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 517 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 518 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 519 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 520 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 521 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 522 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 523 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 524 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 525 MIDDLE EAST: KEY MACROECONOMIC INDICATORS
  • TABLE 526 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 527 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 528 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 529 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 530 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 531 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 532 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 533 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 534 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 535 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 536 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 537 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 538 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 539 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 540 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 541 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 542 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 543 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 544 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 545 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 546 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 547 REST OF MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 548 AFRICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 549 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 550 AFRICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 551 AFRICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022-2029 (USD MILLION)
  • TABLE 552 AFRICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 553 AFRICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 554 AFRICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 555 AFRICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 556 AFRICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 557 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 558 AFRICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 559 AFRICA: KEY MACROECONOMIC INDICATORS
  • TABLE 560 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEIN EXPRESSION MARKET, JANUARY 2021-SEPTEMBER 2024
  • TABLE 561 PROTEIN EXPRESSION MARKET: DEGREE OF COMPETITION
  • TABLE 562 PROTEIN EXPRESSION MARKET: REGION FOOTPRINT
  • TABLE 563 PROTEIN EXPRESSION MARKET: OFFERING FOOTPRINT
  • TABLE 564 PROTEIN EXPRESSION MARKET: EXPRESSION SYSTEM FOOTPRINT
  • TABLE 565 PROTEIN EXPRESSION MARKET: APPLICATION FOOTPRINT
  • TABLE 566 PROTEIN EXPRESSION MARKET: DETAILED LIST OF KEY STARTUP/SMES
  • TABLE 567 PROTEIN EXPRESSION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 568 PROTEIN EXPRESSION MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 569 PROTEIN EXPRESSION MARKET: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 570 PROTEIN EXPRESSION MARKET: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 571 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 572 THERMO FISHER SCIENTIFIC INC.: PRODUCTS AND SERVICES OFFERED
  • TABLE 573 THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 574 THERMO FISHER SCIENTIFIC, INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 575 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 576 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 577 MERCK KGAA: PRODUCTS AND SERVICES OFFERED
  • TABLE 578 MERCK KGAA: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 579 MERCK KGAA: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 580 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 581 DANAHER CORPORATION: PRODUCTS AND SERVICES OFFERED
  • TABLE 582 DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 583 DANAHER CORPORATION: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 584 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 585 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 586 AGILENT TECHNOLOGIES, INC.: PRODUCTS AND SERVICES OFFERED
  • TABLE 587 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 588 SARTORIUS AG: PRODUCTS AND SERVICES OFFERED
  • TABLE 589 SARTORIUS AG: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 590 SARTORIUS AG: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 591 GENSCRIPT: COMPANY OVERVIEW
  • TABLE 592 GENSCRIPT: PRODUCTS AND SERVICES OFFERED
  • TABLE 593 GENSCRIPT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 594 TAKARA BIO INC.: COMPANY OVERVIEW
  • TABLE 595 TAKARA BIO INC.: PRODUCTS AND SERVICES OFFERED
  • TABLE 596 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 597 BIO-RAD LABORATORIES, INC.: PRODUCTS AND SERVICES OFFERED
  • TABLE 598 QIAGEN: COMPANY OVERVIEW
  • TABLE 599 QIAGEN: PRODUCTS AND SERVICES OFFERED
  • TABLE 600 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 601 CHARLES RIVER LABORATORIES: PRODUCTS AND SERVICES OFFERED
  • TABLE 602 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 603 CORNING INCORPORATED: PRODUCTS AND SERVICES OFFERED
  • TABLE 604 LONZA: COMPANY OVERVIEW
  • TABLE 605 LONZA: PRODUCTS AND SERVICES OFFERED
  • TABLE 606 LONZA: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 607 LONZA: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 608 FUJIFILM IRVINE SCIENTIFIC, INC.: COMPANY OVERVIEW
  • TABLE 609 FUJIFILM IRVINE SCIENTIFIC, INC.: PRODUCTS AND SERVICES OFFERED
  • TABLE 610 FUJIFILM IRVINE SCIENTIFIC, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 611 FUJIFILM IRVINE SCIENTIFIC, INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 612 FUJIFILM IRVINE SCIENTIFIC, INC.: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 613 SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW
  • TABLE 614 SYNGENE INTERNATIONAL LIMITED: PRODUCTS AND SERVICES OFFERED
  • TABLE 615 SYNGENE INTERNATIONAL LIMITED: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 616 LGC LIMITED: COMPANY OVERVIEW
  • TABLE 617 LGC LIMITED: PRODUCTS AND SERVICES OFFERED
  • TABLE 618 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 619 EUROFINS SCIENTIFIC: PRODUCTS AND SERVICES OFFERED
  • TABLE 620 AJINOMOTO CO., INC.: COMPANY OVERVIEW
  • TABLE 621 AJINOMOTO CO., INC.: PRODUCTS AND SERVICES OFFERED
  • TABLE 622 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 623 SINO BIOLOGICAL, INC.: COMPANY OVERVIEW
  • TABLE 624 RAYBIOTECH, INC.: COMPANY OVERVIEW
  • TABLE 625 BIONEER CORPORATION: COMPANY OVERVIEW
  • TABLE 626 ORIGENE TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 627 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
  • TABLE 628 ACCURUS BIOSCIENCES: COMPANY OVERVIEW
  • TABLE 629 ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW
  • TABLE 630 OXFORD EXPRESSION TECHNOLOGIES LTD: COMPANY OVERVIEW
  • TABLE 631 PROTEOGENIX INC.: COMPANY OVERVIEW
  • TABLE 632 ABEOMICS: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 PROTEIN EXPRESSION MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 PROTEIN EXPRESSION MARKET: RESEARCH DESIGN
  • FIGURE 3 PROTEIN EXPRESSION MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 4 PROTEIN EXPRESSION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 5 GLOBAL MARKET SIZE ESTIMATION FOR OFFERINGS: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023
  • FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023
  • FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 9 PROTEIN EXPRESSION MARKET: CAGR PROJECTIONS
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 PROTEIN EXPRESSION MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 PROTEIN EXPRESSION PRODUCTS MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 GEOGRAPHICAL SNAPSHOT OF PROTEIN EXPRESSION MARKET
  • FIGURE 18 INCREASING DEMAND FOR PROTEIN BIOLOGICS TO DRIVE MARKET
  • FIGURE 19 US AND PRODUCTS SEGMENT DOMINATED NORTH AMERICAN PROTEIN EXPRESSION MARKET IN 2023
  • FIGURE 20 MAMMALIAN CELL EXPRESSION SYSTEM TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 21 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2023
  • FIGURE 22 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT REGISTERED HIGHEST MARKET SHARE IN 2023
  • FIGURE 23 CHINA TO HAVE HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 24 PROTEIN EXPRESSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 APPROVED DRUGS AND BIOLOGICS IN US, 2014-2024
  • FIGURE 26 APPROVED DRUG TYPE IN US, 2023
  • FIGURE 27 APPROVED PERSONALIZED MEDICINES IN US, 2014-2023
  • FIGURE 28 REVENUE SHIFT AND NEW POCKETS FOR PLAYERS IN PROTEIN EXPRESSION MARKET
  • FIGURE 29 AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION PRODUCTS, 2021-2023
  • FIGURE 30 AVERAGE SELLING PRICE OF SYSTEM TYPES, BY KEY PLAYER, 2023
  • FIGURE 31 AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION INSTRUMENTS, BY KEY PLAYER, 2021-2023
  • FIGURE 32 AVERAGE SELLING PRICE OF PROTEIN EXPRESSION CONSUMABLE PRODUCTS, BY REGION, 2023
  • FIGURE 33 AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION INSTRUMENTS, BY REGION, 2021-2023
  • FIGURE 34 PROTEIN EXPRESSION MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 35 PROTEIN EXPRESSION PRODUCTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 36 PROTEIN EXPRESSION SERVICES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 37 PROTEIN EXPRESSION MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 38 TYPES OF EXPRESSION SYSTEMS
  • FIGURE 39 METHODS OF PROTEIN EXTRACTION
  • FIGURE 40 PROTEIN EXPRESSION MARKET: PATENT ANALYSIS, JANUARY 2014-SEPTEMBER 2024
  • FIGURE 41 PROTEIN EXPRESSION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 42 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
  • FIGURE 43 KEY BUYING CRITERIA FOR PROTEIN EXPRESSION PRODUCTS, BY END USER
  • FIGURE 44 KEY BUYING CRITERIA FOR PROTEIN EXPRESSION SERVICES, BY END USER
  • FIGURE 45 NORTH AMERICA: PROTEIN EXPRESSION MARKET SNAPSHOT
  • FIGURE 46 ASIA PACIFIC: PROTEIN EXPRESSION MARKET SNAPSHOT
  • FIGURE 47 REVENUE ANALYSIS OF KEY PLAYERS, 2021-2023 (USD MILLION)
  • FIGURE 48 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
  • FIGURE 49 PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 50 PROTEIN EXPRESSION MARKET: COMPANY FOOTPRINT
  • FIGURE 51 PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 52 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024
  • FIGURE 53 EV/EBITDA OF KEY VENDORS, 2024
  • FIGURE 54 PROTEIN EXPRESSION MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 55 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 56 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 57 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 58 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 59 SARTORIUS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 60 GENSCRIPT: COMPANY SNAPSHOT (2023)
  • FIGURE 61 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 62 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 63 QIAGEN: COMPANY SNAPSHOT (2023)
  • FIGURE 64 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2023)
  • FIGURE 65 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
  • FIGURE 66 LONZA: COMPANY SNAPSHOT (2023)
  • FIGURE 67 FUJIFILM IRVINE SCIENTIFIC, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 68 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2023)
  • FIGURE 69 LGC LIMITED: COMPANY SNAPSHOT (2023)
  • FIGURE 70 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
  • FIGURE 71 AJINOMOTO CO., INC.: COMPANY SNAPSHOT (2023)